Jitka Abrahámová

598 total citations
44 papers, 406 citations indexed

About

Jitka Abrahámová is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Jitka Abrahámová has authored 44 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Jitka Abrahámová's work include Multiple and Secondary Primary Cancers (11 papers), Testicular diseases and treatments (8 papers) and Renal cell carcinoma treatment (5 papers). Jitka Abrahámová is often cited by papers focused on Multiple and Secondary Primary Cancers (11 papers), Testicular diseases and treatments (8 papers) and Renal cell carcinoma treatment (5 papers). Jitka Abrahámová collaborates with scholars based in Czechia, Russia and Slovakia. Jitka Abrahámová's co-authors include Tomáš Büchler, Ladislav Dušek, Rostislav Vyzula, Bohuslav Melichar, Tomáš Pavlík, Zbyněk Bortlíček, Alexandr Poprach, Igor Puzanov, Ludmila Boublíková and Petr Brabec and has published in prestigious journals such as Cancer, Annals of Oncology and The Oncologist.

In The Last Decade

Jitka Abrahámová

37 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jitka Abrahámová Czechia 10 182 168 147 95 91 44 406
Maria Nirvana Formiga Brazil 12 186 1.0× 118 0.7× 142 1.0× 62 0.7× 85 0.9× 39 360
Hans M. Westgeest Netherlands 13 189 1.0× 108 0.6× 150 1.0× 64 0.7× 94 1.0× 48 423
Guillaume Mouillet France 11 319 1.8× 146 0.9× 212 1.4× 77 0.8× 105 1.2× 33 465
Shan Zheng China 13 103 0.6× 106 0.6× 271 1.8× 60 0.6× 133 1.5× 41 482
Ratislav Bahleda France 12 128 0.7× 168 1.0× 218 1.5× 64 0.7× 114 1.3× 31 458
Guillaume Beinse France 12 93 0.5× 138 0.8× 125 0.9× 41 0.4× 160 1.8× 33 361
Cyril Foa France 12 181 1.0× 67 0.4× 181 1.2× 80 0.8× 74 0.8× 31 457
Carlos E. Bermejo United States 12 154 0.8× 163 1.0× 128 0.9× 250 2.6× 67 0.7× 15 510
Marilyn Mulay United States 11 250 1.4× 243 1.4× 365 2.5× 71 0.7× 104 1.1× 17 644
Jong Seok Lee South Korea 12 146 0.8× 66 0.4× 215 1.5× 96 1.0× 56 0.6× 18 478

Countries citing papers authored by Jitka Abrahámová

Since Specialization
Citations

This map shows the geographic impact of Jitka Abrahámová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jitka Abrahámová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jitka Abrahámová more than expected).

Fields of papers citing papers by Jitka Abrahámová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jitka Abrahámová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jitka Abrahámová. The network helps show where Jitka Abrahámová may publish in the future.

Co-authorship network of co-authors of Jitka Abrahámová

This figure shows the co-authorship network connecting the top 25 collaborators of Jitka Abrahámová. A scholar is included among the top collaborators of Jitka Abrahámová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jitka Abrahámová. Jitka Abrahámová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wohlfahrt, Peter, Jan Bruthans, Alena Krajčoviechová, et al.. (2020). Systematic COronary Risk Evaluation (SCORE) and 20-year risk of cardiovascular mortality and cancer. European Journal of Internal Medicine. 79. 63–69. 8 indexed citations
2.
Dvořák, Josef, Ladislav Dušek, Alžběta Filipová, et al.. (2019). Association of the combined parameters including the frequency of primary cilia, CD8+ tumor infiltrating lymphocytes and PD-1 expression with the outcome in intestinal cancer.. PubMed. 22(6). 1477–1487. 3 indexed citations
3.
4.
Bortlíček, Zbyněk, et al.. (2017). Locally advanced breast cancer in elderly patients. Biomedical Papers. 161(2). 217–222. 7 indexed citations
5.
Dušek, Ladislav, Tomáš Pavlík, Ondřej Májek, et al.. (2015). Estimating Cancer Incidence, Prevalence, and the Number of Cancer Patients Treated with Anti-tumor Th erapy in 2015 and 2020 – Analysis of the Czech National Cancer Registry. Klinicka onkologie. 28(1). 30–43. 8 indexed citations
6.
Dušek, Ladislav, Jan Mužı́k, Tomáš Pavlík, et al.. (2014). Cancer Incidence and Mortality in the Czech Republic. Klinicka onkologie. 27(6). 406–423. 38 indexed citations
7.
8.
Boublíková, Ludmila, Tomáš Büchler, Jan Starý, Jitka Abrahámová, & Jan Trka. (2013). Molecular biology of testicular germ cell tumors: Unique features awaiting clinical application. Critical Reviews in Oncology/Hematology. 89(3). 366–385. 35 indexed citations
9.
Pavlík, Tomáš, Ondřej Májek, Tomáš Büchler, et al.. (2013). Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000–2008. Cancer Epidemiology. 38(1). 28–34. 23 indexed citations
10.
Büchler, Tomáš, et al.. (2012). Positron emission tomography and clinical predictors of survival in primary extragonadal germ cell tumors.. PubMed. 25(3). 178–83. 4 indexed citations
11.
Büchler, Tomáš, Tomáš Pavlík, Zbyněk Bortlíček, et al.. (2012). Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma. Medical Oncology. 29(5). 3321–3324. 12 indexed citations
12.
Poprach, Alexandr, Tomáš Pavlík, Bohuslav Melichar, et al.. (2012). Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study. Annals of Oncology. 23(12). 3137–3143. 88 indexed citations
13.
Büchler, Tomáš, et al.. (2011). Detection of second malignancies during long‐term follow‐up of testicular cancer survivors. Cancer. 117(18). 4212–4218. 11 indexed citations
14.
Büchler, Tomáš, Bohuslav Melichar, Petr Brabec, et al.. (2011). Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry. Annals of Oncology. 23(2). 395–401. 57 indexed citations
15.
Dušek, Ladislav, Jitka Abrahámová, Jan Mužı́k, et al.. (2009). Populační odhady počtu nemocných s kolorektálním karcinomem -jeden z nástrojů včasné diagnostiky časných stadií a rekurenceonemocnění. 5. 1 indexed citations
16.
Dušek, Ladislav, et al.. (2008). Multivariate analysis of risk factors for testicular cancer: a hospital-based case-control study in the Czech Republic.. PubMed. 55(4). 356–68. 22 indexed citations
17.
Abrahámová, Jitka, et al.. (2005). Nádory varlete z Leydigových a Sertoliho buněk. 9(3). 16–19. 1 indexed citations
18.
Abrahámová, Jitka, et al.. (1981). HLA-Antigene bei germinativen Tumoren von verschiedener Lokalisierung. Oncology Research and Treatment. 4(1). 19–20. 2 indexed citations
19.
Abrahámová, Jitka, et al.. (1980). Hemangioma and HLA‐B40 Antigen. Tissue Antigens. 15(2). 220–221. 4 indexed citations
20.
Abrahámová, Jitka, et al.. (1980). Perinatal subglottic and hepatic hemangiomas as potential emergencies: effect of radiotherapy.. PubMed. 27(3). 337–44. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Nirvana Formiga Breakdown of academic impact, for papers by Hans M. Westgeest Breakdown of academic impact, for papers by Guillaume Mouillet Breakdown of academic impact, for papers by Shan Zheng Breakdown of academic impact, for papers by Ratislav Bahleda Breakdown of academic impact, for papers by Guillaume Beinse Breakdown of academic impact, for papers by Cyril Foa Breakdown of academic impact, for papers by Carlos E. Bermejo Breakdown of academic impact, for papers by Marilyn Mulay Breakdown of academic impact, for papers by Jong Seok Lee
Rankless by CCL
2026